Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003

PARP inhibitors modulate upregulation of uPA gene expression in transformed endothelial cells

R. Caldini, L. Ciarpallini, M. Del Rosso, E. Barletta, M. Chevanne

Med Sci Monit 2003; 9(1): 6-0 :: ID: 14991


Tumor growth and metastasis are complex processes which involve cell adhesion, proteolytic degradation of extracellular matrix and basement membrane, and cell migration. Several studies have demonstrated a pivotal role of the urokinase-type plasminogen activator (uPA) system in tumor growth, angiogenesis, and metastasis. In fact uPA and uPA receptor (uPAR) are overexpressed by many tumors and their expression correlates with tumor progression and poor prognosis, while downregulation of uPA or uPAR reduces invasiveness and tumorigenesis. In this study we demonstrate that FGF2 upregulation of uPA gene expression is mediated by poly(ADP-ribose) polymerase(PARP) activity. In fact. A specific inhibitor of PARP activity such as 3-aminobenzamide, as well as NAD+ deprivation, prevents FGF2-mediated uPA gene upregulation and cell-associated uPA production in transformed foetal bovine aortic endothelial cells GM7373. We also provide evidence that FGF2 enhances PARP activity by MAPK-dependent phosphorylation. It is noteworthy that also uPA-uPAR interaction controls uPA production through MAPK-dependent activation.Identification of the pathway which modulates upregulation of uPA gene expression, following MAPK activation, may be a new therapeutic target in anticancer therapy. In particular drugs which inhibit PARP activity could be relevant in the control of tumor angiogenesis and metastasis.

Keywords: PARP, uPA, FGF2, MAPK, GM7373 cells

Add Comment 0 Comments

309 0


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750